MPN & GvHD | Virtual Congress

.atomic-select.jsAtomicSelect { display: none; }

Disease Education

Disease Education Clinical Trials

Reimagining Medicine for Patients With MPNs & GvHD

Striving for optimal clinical outcomes for patients with MPNs and GvHD to change the course of their disease

MPN = Myeloproliferative Neoplasm; GvHD = Graft versus Host Disease.

Explore Clinical Trials

GvHD

REACH5

Activity, Safety, and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs Host Disease After Allogeneic Stem Cell Transplant

MPN

ADORE

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

MPN = Myeloproliferative Neoplasm; GvHD = Graft versus Host Disease.

.lazy { display: none; }

Use of website is governed by the Terms of Use and Privacy Policy.

5/21 121333